The Health Science Authority (HSA) and Agency for Care Effectivness (ACE) in Singapore have recently published a new patient fact sheet on safe usage of allopurinol.
Medical education constantly evolves to meet the needs of patients, and a new allopurinol patient factsheet provides a great example of how better communication can make a significant difference in patient safety and outcomes. This new patient factsheet for allopurinol usage in treating gout will enhance patient safety and the effective management of this painful condition. As a cornerstone in the management of gout, allopurinol has been in use for decades. The new patient factsheet provides clear and accessible information for patients. In particular, it provides important information regarding adverse effects, particularly the rare but serious condition known as Severe Cutaneous Adverse Reaction (SCAR), for patients taking allopurinol.